{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:57:24Z","timestamp":1772121444495,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T00:00:00Z","timestamp":1679788800000},"content-version":"am","delay-in-days":298,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R00DA040744"],"award-info":[{"award-number":["R00DA040744"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.neuropharm.2022.109040","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T02:50:05Z","timestamp":1647571805000},"page":"109040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Domain-selective BET inhibition attenuates transcriptional and behavioral responses to cocaine"],"prefix":"10.1016","volume":"210","author":[{"given":"Mandakini B.","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Babigian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory C.","family":"Sartor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2022.109040_bib1","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1016\/S2352-3026(16)00021-1","article-title":"Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study","volume":"3","author":"Amorim","year":"2016","journal-title":"Lancet. Haematol."},{"key":"10.1016\/j.neuropharm.2022.109040_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113644","article-title":"JQ1 attenuates psychostimulant- but not opioid-induced conditioned place preference","volume":"418","author":"Babigian","year":"2022","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuropharm.2022.109040_bib3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.atherosclerosis.2017.03.019","article-title":"Vascular disease in cocaine addiction","volume":"262","author":"Bachi","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.neuropharm.2022.109040_bib4","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1073\/pnas.092654299","article-title":"Decreased expression of the transcription factor NURR1 in dopamine neurons of cocaine abusers","volume":"99","author":"Bannon","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2022.109040_bib5","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.1016\/S2352-3026(15)00247-1","article-title":"Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study","volume":"3","author":"Berthon","year":"2016","journal-title":"Lancet. Haematol."},{"key":"10.1016\/j.neuropharm.2022.109040_bib6","doi-asserted-by":"crossref","first-page":"S353","DOI":"10.33549\/physiolres.934348","article-title":"Sex-related differences in locomotion and climbing of C57Bl\/6NTac mice in a novel environment","volume":"68","author":"Borb\u00e9lyov\u00e1","year":"2019","journal-title":"Physiol. Res."},{"key":"10.1016\/j.neuropharm.2022.109040_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2010.06.004","article-title":"AMPA receptor synaptic plasticity induced by psychostimulants: the past, present, and therapeutic future","volume":"67","author":"Bowers","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109040_bib8","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41467-020-14331-y","article-title":"Nr4a1 suppresses cocaine-induced behavior via epigenetic regulation of homeostatic target genes","volume":"11","author":"Carpenter","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2022.109040_bib9","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0325-18.2019","article-title":"Fosb induction in nucleus accumbens by cocaine is regulated by E2F3a","volume":"6","author":"Cates","year":"2019","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2022.109040_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ddtec.2016.05.003","article-title":"Phospho-BRD4: transcription plasticity and drug targeting","volume":"19","author":"Chiang","year":"2016","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.neuropharm.2022.109040_bib12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature10509","article-title":"Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia","volume":"478","author":"Dawson","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109040_bib13","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.biopsych.2016.09.015","article-title":"Striatal H3K27 acetylation linked to glutamatergic gene dysregulation in human heroin abusers holds promise as therapeutic target","volume":"81","author":"Egervari","year":"2017","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109040_bib14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41586-020-1930-8","article-title":"Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer","volume":"578","author":"Faivre","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109040_bib15","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109040_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1126\/science.aaz8455","article-title":"Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation","volume":"368","author":"Gilan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109040_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.atherosclerosis.2016.01.036","article-title":"RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I\/HDL and represses pathways that contribute to cardiovascular disease","volume":"247","author":"Gilham","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.neuropharm.2022.109040_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12808","article-title":"Role of BRD4 phosphorylation in the nucleus accumbens in relapse to cocaine-seeking behavior in mice","volume":"25","author":"Guo","year":"2020","journal-title":"Addiction Biol."},{"key":"10.1016\/j.neuropharm.2022.109040_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1998.tb08216.x","article-title":"Cocaine and the AP-1 transcription factor complex","volume":"844","author":"Hope","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2022.109040_bib20","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1128\/MCB.01365-08","article-title":"Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA","volume":"29","author":"Huang","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.neuropharm.2022.109040_bib21","doi-asserted-by":"crossref","first-page":"110226","DOI":"10.1016\/j.cellsig.2021.110226","article-title":"A role for BET proteins in regulating basal, dopamine-induced and cAMP\/PKA-dependent transcription in rat striatal neurons","volume":"91","author":"Jones-Tabah","year":"2022","journal-title":"Cell. Signal."},{"key":"10.1016\/j.neuropharm.2022.109040_bib22","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nn.3354","article-title":"Class I HDAC inhibition blocks cocaine-induced plasticity by targeted changes in histone methylation","volume":"16","author":"Kennedy","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109040_bib23","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/nn.4095","article-title":"BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice","volume":"18","author":"Korb","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109040_bib24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bbr.2014.11.018","article-title":"Multiple faces of BDNF in cocaine addiction","volume":"279","author":"Li","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109040_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/13543776.2020.1702645","article-title":"A patent review of BRD4 inhibitors (2013-2019)","volume":"30","author":"Lu","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.neuropharm.2022.109040_bib26","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1073\/pnas.1213364110","article-title":"HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner","volume":"110","author":"Malvaez","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2022.109040_bib27","doi-asserted-by":"crossref","first-page":"16941","DOI":"10.1523\/JNEUROSCI.2747-11.2011","article-title":"CBP in the nucleus accumbens regulates cocaine-induced histone acetylation and is critical for cocaine-associated behaviors","volume":"31","author":"Malvaez","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109040_bib28","first-page":"357","article-title":"RVX-208, a stimulator of apolipoprotein AI gene expression for the treatment of cardiovascular diseases","volume":"11","author":"McNeill","year":"2010","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.neuropharm.2022.109040_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0091-679X(03)01007-0","article-title":"Culturing hippocampal and cortical neurons","volume":"71","author":"Meberg","year":"2003","journal-title":"Methods Cell Biol"},{"key":"10.1016\/j.neuropharm.2022.109040_bib30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.healthpol.2010.12.002","article-title":"The cost of drug development: a systematic review","volume":"100","author":"Morgan","year":"2011","journal-title":"Health Pol."},{"key":"10.1016\/j.neuropharm.2022.109040_bib31","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jacc.2010.11.015","article-title":"Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-treated patients with stable coronary artery disease a randomized controlled trial","volume":"57","author":"Nicholls","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.neuropharm.2022.109040_bib32","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/nature09589","article-title":"Suppression of inflammation by a synthetic histone mimic","volume":"468","author":"Nicodeme","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109040_bib33","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1517\/13543784.2015.1083010","article-title":"An evaluation of RVX-208 for the treatment of atherosclerosis","volume":"24","author":"Nikolic","year":"2015","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.neuropharm.2022.109040_bib34","doi-asserted-by":"crossref","first-page":"172818","DOI":"10.1016\/j.pbb.2019.172818","article-title":"The activity-regulated cytoskeleton-associated protein, Arc\/Arg3.1, influences mouse cocaine self-administration","volume":"188","author":"Penrod","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2022.109040_bib35","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cbpa.2020.02.003","article-title":"Domain-selective targeting of BET proteins in cancer and immunological diseases","volume":"57","author":"Petretich","year":"2020","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.neuropharm.2022.109040_bib36","doi-asserted-by":"crossref","first-page":"19754","DOI":"10.1073\/pnas.1310658110","article-title":"RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain","volume":"110","author":"Picaud","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2022.109040_bib37","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.1523\/JNEUROSCI.4472-12.2013","article-title":"HDAC3 is a negative regulator of cocaine-context-associated memory formation","volume":"33","author":"Rogge","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109040_bib38","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/npp.2012.154","article-title":"The role of histone acetylation in cocaine-induced neural plasticity and behavior","volume":"38","author":"Rogge","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109040_bib39","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.biopsych.2016.05.025","article-title":"Activity-regulated cytoskeleton-associated protein accumulates in the nucleus in response to cocaine and acts as a brake on chromatin remodeling and long-term behavioral alterations","volume":"81","author":"Salery","year":"2017","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109040_bib40","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bcp.2019.07.012","article-title":"Epigenetic pharmacotherapy for substance use disorder","volume":"168","author":"Sartor","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109040_bib41","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1523\/JNEUROSCI.4561-11.2012","article-title":"A septal-hypothalamic pathway drives orexin neurons, which is necessary for conditioned cocaine preference","volume":"32","author":"Sartor","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109040_bib42","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1523\/JNEUROSCI.1604-18.2018","article-title":"Enhancement of BDNF expression and memory by HDAC inhibition requires BET bromodomain reader proteins","volume":"39","author":"Sartor","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109040_bib43","doi-asserted-by":"crossref","first-page":"15062","DOI":"10.1523\/JNEUROSCI.0826-15.2015","article-title":"Epigenetic readers of lysine acetylation regulate cocaine-induced plasticity","volume":"35","author":"Sartor","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109040_bib44","doi-asserted-by":"crossref","first-page":"108306","DOI":"10.1016\/j.neuropharm.2020.108306","article-title":"BET bromodomains as novel epigenetic targets for brain health and disease","volume":"181","author":"Singh","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109040_bib46","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1084\/jem.20151271","article-title":"Autism-like syndrome is induced by pharmacological suppression of BET proteins in young mice","volume":"212","author":"Sullivan","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuropharm.2022.109040_bib47","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/nchembio.2209","article-title":"Design and characterization of bivalent BET inhibitors","volume":"12","author":"Tanaka","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuropharm.2022.109040_bib48","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13148-019-0696-z","article-title":"Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism","volume":"11","author":"Tsujikawa","year":"2019","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.neuropharm.2022.109040_bib49","first-page":"867","article-title":"Cocaine self-administration alters transcriptome-wide responses in the brain's reward circuitry","volume":"84","author":"Walker","year":"2018","journal-title":"Biol. Psychiatr. Cocaine Addiction Obsessive Compulsive Disord. Corticostriatal Plast."},{"key":"10.1016\/j.neuropharm.2022.109040_bib50","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13148-020-00943-0","article-title":"BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes","volume":"12","author":"Wasiak","year":"2020","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.neuropharm.2022.109040_bib51","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1038\/s41467-019-09672-2","article-title":"A chemical toolbox for the study of bromodomains and epigenetic signaling","volume":"10","author":"Wu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2022.109040_bib52","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.molcel.2012.12.006","article-title":"Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting","volume":"49","author":"Wu","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuropharm.2022.109040_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1432.049","article-title":"c-Fos is an intracellular regulator of cocaine-induced long-term changes","volume":"1139","author":"Xu","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2022.109040_bib54","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cbpa.2017.06.012","article-title":"Chemical modulators for epigenome reader domains as emerging epigenetic therapies for cancer and inflammation","volume":"39","author":"Zaware","year":"2017","journal-title":"Curr. Opin. Chem. Biol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822000995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822000995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:18:57Z","timestamp":1758439137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390822000995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":52,"alternative-id":["S0028390822000995"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109040","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.10.04.463083","asserted-by":"object"}]},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Domain-selective BET inhibition attenuates transcriptional and behavioral responses to cocaine","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109040"}}